Trevi Therapeutics, Inc. TRVI Stock Issued During Period Value Stock Warrant Exercise
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept trvi:StockIssuedDuringPeriodValueStockWarrantExercise.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed August 7, 2025, on SEC EDGAR. View the filing →
Questions, answered.
- What is Trevi Therapeutics, Inc.'s stock issued during period value stock warrant exercise?
- Trevi Therapeutics, Inc. (TRVI) reported stock issued during period value stock warrant exercise of $2.54M in Q2 2025.